A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes (Q61975386)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes |
clinical trial |
Statements
A Multicenter Randomized, Double-blind, Placebo Controlled ,Parallel Group ,Phase III Study to Access the Efficacy and Safety of SP2086 in Combination Therapy With Metformin in Patients With Type 2 Diabetes Patients (English)
0 references
April 2013
0 references
January 2014
0 references
360
0 references
18 year
0 references
80 year
0 references